Ignite Creation Date:
2025-12-24 @ 1:15 PM
Ignite Modification Date:
2026-01-20 @ 1:44 AM
Study NCT ID:
NCT00404495
Status:
COMPLETED
Last Update Posted:
2012-04-18
First Post:
2006-11-27
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Combination of Irinotecan and Temozolomide in Children With Brain Tumors.
Sponsor:
Pfizer
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
A5961166
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None